Cairo – Mubahser: The Egyptian Exchange (EGX) announced that it will continue to halt trading on the stocks of Golden Pyramids Plaza, Middle East Glass Manufacturing Company (MEG), and Glaxo SmithKline (GSK Egypt) as the three companies have not disclosed their financial results.

Trading suspension on Golden Pyramids Plaza’s stock will continue as the company has not disclosed its standalone financial results for the first quarter of 2019 as well as its consolidated financial results for the fiscal year ended 31 December, the EGX said in a statement on Sunday.

Moreover, the EGX will continue to halt trading on MEG’s stock until the firm discloses its financial results for the fiscal year ended 31 March.

In addition, trading suspension will also continue on GSK Egypt’s stock as the company has not disclosed its standalone and consolidated financial results for fiscal periods ended 30 September 2018 and 31 December 2018, respectively, as well as its standalone financial results for Q1-19.